(2024) 121:e2402903121
Nausea from tirzepatide Nausea is the most common complaint, affecting up to one-third of tirzepatide users at higher doses
First, it is difficult for GLP-1 agonists to achieve anti-fibrosis effects because the major effect of GLP-1 agonists on MASH is likely to be indirect by extrahepatic path
Our goal is to provide every patient with safe, effective solutions that promote both health and confidence
The answer depends on a few factors, including your overall health, your doctors recommendations, and the severity of your illness
Consult a healthcare provider if you experience: Persistent injection site reactions, signs of allergic reaction (rash, difficulty breathing, swelling), or any concerning symptoms that do not resolve quickly